Alternatively, the increase in inflammatory mediators which was also observed in the OA microenvironment and changes in RA synovial tissue pathologic findings even after active treatment, could also contribute to the comparable PKM2 qPCR results (46, 47). The gene discussed is PKM; the disease is rheumatoid arthritis.